Halil Kömek

743 total citations
60 papers, 508 citations indexed

About

Halil Kömek is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Halil Kömek has authored 60 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 28 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Halil Kömek's work include Radiomics and Machine Learning in Medical Imaging (17 papers), Medical Imaging Techniques and Applications (15 papers) and Peptidase Inhibition and Analysis (14 papers). Halil Kömek is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (17 papers), Medical Imaging Techniques and Applications (15 papers) and Peptidase Inhibition and Analysis (14 papers). Halil Kömek collaborates with scholars based in Türkiye, Somalia and United States. Halil Kömek's co-authors include Canan Can, Cihan Gündoğan, Yunus Güzel, İhsan Kaplan, Zeynep Oruç, Bahri Çakabay, Özlem Abakay, Tansel Ansal Balcı, Uğur Yılmaz and Abdurrahman Abakay and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Nuclear Medicine and Molecular Imaging and BMC Gastroenterology.

In The Last Decade

Halil Kömek

48 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halil Kömek Türkiye 13 331 199 179 154 147 60 508
Cihan Gündoğan Türkiye 10 290 0.9× 175 0.9× 141 0.8× 96 0.6× 143 1.0× 44 425
Canan Can Türkiye 11 314 0.9× 189 0.9× 131 0.7× 89 0.6× 168 1.1× 41 441
Huipan Liu China 13 366 1.1× 213 1.1× 112 0.6× 68 0.4× 237 1.6× 48 453
Emine Göknur Işık Türkiye 10 169 0.5× 71 0.4× 128 0.7× 118 0.8× 66 0.4× 41 313
Esra Arslan Türkiye 9 133 0.4× 119 0.6× 115 0.6× 52 0.3× 55 0.4× 65 281
A. Spada Italy 9 227 0.7× 85 0.4× 56 0.3× 179 1.2× 67 0.5× 17 425
Ana Castro Portugal 8 239 0.7× 69 0.3× 53 0.3× 220 1.4× 199 1.4× 13 577
Outi Paija Finland 6 443 1.3× 98 0.5× 151 0.8× 93 0.6× 44 0.3× 9 509
Reid Perlman United States 5 98 0.3× 144 0.7× 55 0.3× 177 1.1× 141 1.0× 6 376
David Chung Australia 12 187 0.6× 106 0.5× 80 0.4× 62 0.4× 115 0.8× 40 405

Countries citing papers authored by Halil Kömek

Since Specialization
Citations

This map shows the geographic impact of Halil Kömek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Kömek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Kömek more than expected).

Fields of papers citing papers by Halil Kömek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halil Kömek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Kömek. The network helps show where Halil Kömek may publish in the future.

Co-authorship network of co-authors of Halil Kömek

This figure shows the co-authorship network connecting the top 25 collaborators of Halil Kömek. A scholar is included among the top collaborators of Halil Kömek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halil Kömek. Halil Kömek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kabasakal, Levent, Nalan Alan Selçuk, Türkay Toklu, et al.. (2025). Istanbul PSMA PET/CT criteria (IPPC): an imaging-based approach to patient selection for active surveillance. European Journal of Nuclear Medicine and Molecular Imaging. 53(5). 3042–3055.
2.
Urakçı, Zuhat, Zeynep Oruç, Halil Kömek, et al.. (2025). Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer. Revista da Associação Médica Brasileira. 71(4). e20240411–e20240411.
3.
Can, Cavit, et al.. (2023). Combination of [68Ga]Ga-PSMA PET/CT and [18F]FDG PET/CT in demonstrating dedifferentiation in castration-resistant prostate cancer. Médecine Nucléaire. 47(4). 193–199. 3 indexed citations
4.
Şimşek, Duygu Has, Yunus Güzel, Yasemin Şanlı, et al.. (2023). The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 828–840. 4 indexed citations
6.
Gündoğan, Cihan, et al.. (2022). The effect of prior COVID-19 infection on coronary microvascular dysfunction. Acta cardiologica. Supplementum. 77(8). 693–698. 6 indexed citations
7.
Kömek, Halil, et al.. (2022). Comparison of [68 Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT in colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3898–3909. 61 indexed citations
8.
Akyol, Murat, et al.. (2022). The Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma. Molecular Imaging and Radionuclide Therapy. 31(2). 104–113. 3 indexed citations
9.
Kömek, Halil, et al.. (2022). Evaluation of caregiver burden of cancer patients and impact of this burden on caregiver's quality of life. Journal of Health Sciences and Medicine. 5(1). 313–320. 2 indexed citations
10.
Kömek, Halil, et al.. (2021). The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features. Postgraduate Medicine. 133(6). 694–700. 3 indexed citations
11.
Gündoğan, Cihan, Yunus Güzel, Canan Can, İhsan Kaplan, & Halil Kömek. (2021). FAPI-04 Uptake in Healthy Tissues of Cancer Patients in 68Ga-FAPI-04 PET/CT Imaging. Contrast Media & Molecular Imaging. 2021. 1–7. 20 indexed citations
12.
Kömek, Halil, Canan Can, Yunus Güzel, et al.. (2021). 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT. Annals of Nuclear Medicine. 35(6). 744–752. 102 indexed citations
13.
Can, Canan, et al.. (2021). Nivolumab-Related Dry Mouth and Dry Eye: Cross-Sectional Study. Cancer Investigation. 39(10). 797–807. 3 indexed citations
14.
Kömek, Halil, et al.. (2021). A Case with <sup>68</sup>Ga-FAPI Positive and <sup>18</sup>F-FDG Negative Breast Cancer. Molecular Imaging and Radionuclide Therapy. 30(3). 201–204. 4 indexed citations
16.
Güzel, Yunus, et al.. (2020). Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer. Nuclear Medicine Communications. 41(12). 1322–1327. 4 indexed citations
17.
Can, Canan & Halil Kömek. (2019). Contribution of 5th minute and 2nd hour images to standard imaging in (68Ga)PSMA 11 PET/CT. Annals of Nuclear Medicine. 34(3). 163–173. 2 indexed citations
19.
Kömek, Halil, et al.. (2018). The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors.. PubMed. 21(2). 163–169. 2 indexed citations
20.
Tanrıkulu, Abdullah Çetin, Abdurrahman Abakay, Halil Kömek, & Özlem Abakay. (2016). Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma. Environmental Health and Preventive Medicine. 21(5). 304–311. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026